"10.1371_journal.pone.0083198","plos one","2013-12-31T00:00:00Z","Jan-Willem E M Sels; Bert Rutten; Thijs C van Holten; Marieke A K Hillaert; Johannes Waltenberger; Nico H J Pijls; Gerard Pasterkamp; Philip G de Groot; Mark Roest","Department of Cardiology, Catharina Hospital Eindhoven, Eindhoven, The Netherlands; Department of Clinical Chemistry and Hematology, University Medical Center Utrecht, Utrecht, The Netherlands; Laboratory of Experimental Cardiology, University Medical Center Utrecht, Utrecht, The Netherlands; Department of Biomedical Engineering, Eindhoven University of Technology, Eindhoven, The Netherlands; Department of Cardiology, University Medical Center Utrecht, Utrecht, The Netherlands; Department of Cardiology, Maastricht University Medical Center, Maastricht. The Netherlands; Department of Cardiovascular Medicine, University of Muenster, Muenster, Germany","Conceived and designed the experiments: JS TH BR MR. Performed the experiments: JS TH BR NP MH. Analyzed the data: JS TH BR NP MR. Contributed reagents/materials/analysis tools: TH BR MR GP PG. Wrote the paper: JS BR TH JW NP MR GP.","The authors have read the journal's policy and have the following conflicts. Gerard Pasterkamp is founder of Cavadis, a biomarker company. There is no association with content of this paper. Nico H.J. Pijls has received research grants from St Jude Medical, Abbott and Maquet and is a consultant for St Jude Medical. Other authors have no potential conflicts to disclose. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.","2013","12","Jan-Willem E M Sels","JWEMS",9,TRUE,4,5,5,7,TRUE,TRUE,FALSE,0,NA,FALSE
